Literature DB >> 19924642

Expression of Reg IV and Hath1 in neuroendocrine neoplasms.

Kukka Heiskala1, Johanna Arola, Marja Heiskala, Leif C Andersson.   

Abstract

Reg IV (RELP), a Regenerating protein family member, is constitutively expressed in neuroendocrine cells of the intestinal mucosa. The helix-loop-helix transcription factor Hath1 is the human homologue of murine Math1, which regulates the embryonic differentiation of neural and intestinal secretory lineage cells. Hath1 is constitutively expressed in a subset of mature secretory gastrointestinal cells. We investigated by immunohistochemistry the expression of Reg IV and Hath1 in 63 neuroendocrine tumors. Intestinal neuroendocrine neoplasms showed co-expression of Reg IV and Hath1, as did parathyroidal and Merkel cell tumors. Lung small-cell carcinoma and gastric mucocellular carcinoma expressed only Reg IV. Pancreatic islet-derived tumors, pheochromocytomas, and paragangliomas expressed only Hath1. Lymph node and liver metastases retained the tissue-specific expression patterns. These distinct expression profiles may be useful for differential diagnostics of metastatic lesions of neuroendocrine tumors. The dissimilar expression patterns suggest that the proteins belong to different signaling pathways and are activated at different stages of neuroendocrine differentiation. Local Reg IV expression may be influenced by the growth factors bFGF and HGF and/or their receptors CD138 and c-met, which were found to co-localize with Reg IV in intestinal neuroendocrine tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19924642     DOI: 10.14670/HH-25.63

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  16 in total

1.  NOTCH Signaling and ATOH1 in Colorectal Cancers.

Authors:  Avedis Kazanjian; Noah F Shroyer
Journal:  Curr Colorectal Cancer Rep       Date:  2011-06

Review 2.  Neuroendocrine neoplasms of the gut and pancreas: new insights.

Authors:  Guido Rindi; Bertram Wiedenmann
Journal:  Nat Rev Endocrinol       Date:  2011-08-02       Impact factor: 43.330

3.  Ectopic Atoh1 expression drives Merkel cell production in embryonic, postnatal and adult mouse epidermis.

Authors:  Stephen M Ostrowski; Margaret C Wright; Alexa M Bolock; Xuehui Geng; Stephen M Maricich
Journal:  Development       Date:  2015-07-02       Impact factor: 6.868

4.  Enhanced RegIV expression predicts the intrinsic 5-fluorouracil (5-FU) resistance in advanced gastric cancer.

Authors:  Li-Sha Ying; Jiang-Liu Yu; Xiao-Xiao Lu; Zhi-Qiang Ling
Journal:  Dig Dis Sci       Date:  2012-09-26       Impact factor: 3.199

5.  Prognostic relevance of high atonal homolog-1 expression in Merkel cell carcinoma.

Authors:  T Gambichler; S Mohtezebsade; U Wieland; S Silling; A-K Höh; M Dreißigacker; J Schaller; H-J Schulze; F Oellig; A Kreuter; E Stockfleth; M Stücker; F G Bechara; J C Becker
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-13       Impact factor: 4.553

6.  Serum concentration and expression of Reg IV in patients with esophageal cancer: Age-related elevation of serum Reg IV concentration.

Authors:  Naohide Oue; Tsuyoshi Noguchi; Katsuhiro Anami; Kazuhiro Sentani; Naoya Sakamoto; Naohiro Uraoka; Yuta Wakamatsu; Hiroki Sasaki; Wataru Yasui
Journal:  Oncol Lett       Date:  2011-01-19       Impact factor: 2.967

7.  Oncogenic reg IV is a novel prognostic marker for glioma patient survival.

Authors:  Qi Wang; Jianping Deng; Jun Yuan; Liang Wang; Zhenwei Zhao; Shiming He; Yongsheng Zhang; Yanyang Tu
Journal:  Diagn Pathol       Date:  2012-06-19       Impact factor: 2.644

Review 8.  Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype.

Authors:  Naohide Oue; Kazuhiro Sentani; Naoya Sakamoto; Wataru Yasui
Journal:  Cancer Sci       Date:  2015-07-07       Impact factor: 6.716

9.  REG4 independently predicts better prognosis in non-mucinous colorectal cancer.

Authors:  Tuomas Kaprio; Jaana Hagström; Harri Mustonen; Selja Koskensalo; Leif C Andersson; Caj Haglund
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

10.  Reg IV is a direct target of intestinal transcriptional factor CDX2 in gastric cancer.

Authors:  Yutaka Naito; Naohide Oue; Takao Hinoi; Naoya Sakamoto; Kazuhiro Sentani; Hideki Ohdan; Kazuyoshi Yanagihara; Hiroki Sasaki; Wataru Yasui
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.